C
Crinetics Pharmaceuticals D
D
CRNX
31.290
USD
0.37
(1.20%)
مغلق
حجم التداول
20,545
الربح لكل سهم
-4
العائد الربحي
-
P/E
-8
حجم السوق
2,931,251,268
الأخبار المقالات
العنوان: Crinetics Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.